Evidence map›Paper›PMID 24256364›Full record

ArticleJournal of cellular and molecular medicine2014

Gene polymorphisms and chronic obstructive pulmonary disease.

Xiaodan Wu, Bowei Yuan, Elena López, Chunxue Bai, Xiangdong Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Aging and Lung Disease.Annual review of physiology · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Autophagy and inflammation.Clinical and translational medicine · 2017
    Review
  9. Article
  10. Article
  11. Sirtuin gene polymorphisms are associated with chronic obstructive pulmonary disease in patients in Muğla province.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2014
    Article
  12. Interleukin-6 is a Strong Predictor of the Frequency of COPD Exacerbation Within 1 Year.International journal of chronic obstructive pulmonary disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Xiaodan WuDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Respiratory Research Institute, Shanghai, China.
Bowei Yuan
Elena López
Chunxue Bai
Xiangdong Wang
Fudan University · CNHarbin Medical University · CNHospital Infantil Universitario Niño Jesús · ESZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic component was suggested to contribute to the development of chronic obstructive pulmonary disease (COPD), a major and growing public health burden. The present review aims to characterize the evidence that gene polymorphisms contribute to the aetiology of COPD and related traits, and explore the potential relationship between certain gene polymorphisms and COPD susceptibility, severity, lung function, phenotypes, or drug effects, even though limited results from related studies lacked consistency. Most of these studies were association studies, rather than confirmatory studies. More large-sized and strictly controlled studies are needed to prove the relationship between gene polymorphisms and the reviewed traits. More importantly, prospective confirmatory studies beyond initial association studies will be necessary to evaluate true relationships between gene polymorphisms and COPD and help individualized treatment for patients with COPD.

Indexed as

Polymorphism, Single Nucleotidealpha 1-AntitrypsinDisease ProgressionEpoxide HydrolasesGenetic Association StudiesGenetic Predisposition to DiseaseGlutathione TransferaseHumansPulmonary Disease, Chronic ObstructiveTransforming Growth Factor beta1Tumor Necrosis Factor-alphaalpha 1-AntitrypsinEpoxide HydrolasesGlutathione TransferaseTransforming Growth Factor beta1Tumor Necrosis Factor-alphabiomarkerschronic lung diseasesCOPDgenepolymorphismtherapy

Identifiers

PMID24256364
PMCPMC3916114
OpenAlexW2020151713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.